BEAUTYFARM MED's Subsidiary Acquires RMB80 Million in Capital-Preserving Financial Products

Stock News
Feb 13

BEAUTYFARM MED (02373) announced that on February 13, 2026, to effectively utilize idle funds, its non-wholly-owned subsidiary, Beijing Beilaishi, subscribed for capital-preserving financial products totaling RMB80 million from SPD Bank based on a February 13 subscription agreement. Additionally, through Beijing Beilaishi and Shanghai BEAUTYFARM MED, the company separately subscribed for RMB70 million on November 21, 2025, based on a November 21 agreement; RMB10 million on November 28, 2025, based on a November 28 agreement; and a total of RMB80 million on December 30, 2025, based on a December 30 agreement, all in capital-preserving financial products from SPD Bank. All of the aforementioned products remain outstanding as of the date of this announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10